Friday - August 29, 2025
MD Anderson and BostonGene Announce Strategic Alliance to Advance Personalized Cancer Diagnostics and Treatments
September 29, 2021
HOUSTON, Texas, Sept. 29 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 28, 2021:

The University of Texas MD Anderson Cancer Center and BostonGene Corporation today announced a strategic alliance to advance the development and clinical integration of multiplatform biomarker signatures.

The alliance brings together BostonGene's innovative computational platform and CLIA-certified and CAP-accredited hig . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products